Search for: "PREFERRED PHARMACEUTICALS, INC"
Results 181 - 200
of 434
Sort by Relevance
|
Sort by Date
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
11 Apr 2014, 11:29 am
Finally, United States Patent No. 6,468,559 (“Chen”) […] disclosed a preferred embodiment in which “a dosage form of the invention is administered to a patient . . . preferably once a month. [read post]
3 Apr 2014, 5:00 am
Jan. 30, 2014) (“Actos”); In re Ethicon, Inc. [read post]
28 Mar 2014, 5:33 pm
Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and… [read post]
24 Mar 2014, 4:15 am
See Allergan, Inc. v. [read post]
20 Mar 2014, 5:34 pm
Barr’s ANDA filing was second to that of Par Pharmaceuticals, Inc. [read post]
17 Mar 2014, 5:13 pm
Teva Pharmaceuticals USA, Inc., 619 F.3d 1329 (Fed. [read post]
11 Mar 2014, 1:35 pm
Her post is about the First Amendment implications of the FDA's recent draft guidance on manufacturer distribution of scientific articles and textbooks, a proposal that alters, but does not fundamentally change the FDA's previous guidance on this subject that we discussed back in 2009.Take it away Lindsey:********************Last week, the FDA released new draft guidelines that represent its latest recommendations for what drug and device manufacturers should do when they wish to distribute… [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
25 Feb 2014, 2:49 pm
The U.S. company Merck, Inc. is active in Germany under the name “MSD Shark & Dohme”. [read post]
25 Jan 2014, 9:43 am
In re Petition of Boehringer Ingelheim Pharmaceuticals, Inc., No. 13-3898 (7th Cir. [read post]
13 Jan 2014, 4:02 am
Take for example, the pharmaceuticals case of Cephalon Inc v Orchid Europe Ltd [2010] EWHC 2945 (Pat) [briefly noted on PatLit here] in which Floyd J (as he was) treated the issue of who is likely to suffer the most irreparable harm as the key factor in the balance of convenience assessment itself: "Balance of convenienceThere is no dispute as to the approach which I should apply. [read post]
30 Dec 2013, 5:25 am
Takeda Pharmaceutical Co. [read post]
19 Dec 2013, 8:56 pm
Indus., Inc., 199 F.3d 1295, 1302 (Fed. [read post]
18 Dec 2013, 9:00 pm
Tolmar, Inc., No. 2013-1034 (Fed. [read post]
15 Dec 2013, 4:00 am
Pharmaceuticals: GenericsKatz Group Canada Inc. [read post]
11 Dec 2013, 7:55 pm
Depuy Spine, Inc. v. [read post]
4 Dec 2013, 5:05 pm
Grove Fresh Distributors, Inc. v. [read post]
2 Oct 2013, 7:35 pm
Category: Claim Construction By: John Kirkpatrick, Contributor TitleSkinmedica, Inc., v. [read post]
1 Oct 2013, 11:41 am
Despite a showdown in Congress about health care reform’s future that threatens to bring funding of the U.S. government to a halt and a host of recent security and other concerns about the security and operational readiness of its enrollment platform and details of the implementation of the marketplaces in many states that will provide the offered coverage, the Obama Administration is touting today, October 1, 2013, as the first day that Americans can apply for enrollment in coverage offered… [read post]
